Tonix Pharmaceuticals Holding Corp (TNXP)
NASDAQ · Healthcare
Tonix Pharmaceuticals Holding Corp Shareholder Equity 2023–2025
Tonix Pharmaceuticals Holding Corp annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Tonix Pharmaceuticals Holding Corp shareholder equity for the quarter ending December 31, 2025 were 245.2M, a 75.66% increase year-over-year.
- Tonix Pharmaceuticals Holding Corp shareholder equity for 2025 were 245.2M, a 75.66% increase from 2024.
- Tonix Pharmaceuticals Holding Corp shareholder equity for 2024 were 139.6M, a 32.25% increase from 2023.
- Tonix Pharmaceuticals Holding Corp shareholder equity for 2023 were 105.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Tonix Pharmaceuticals Holding Corp Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $245 |
| 2024 | $140 |
| 2023 | $106 |
| Tonix Pharmaceuticals Holding Corp Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $245 |
| 2024-12-31 | $140 |
| 2023-12-31 | $106 |
Tonix Pharmaceuticals Holding Corp Shareholder Equity — FAQ
Tonix Pharmaceuticals Holding Corp (TNXP) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TNXP's shareholder equity history?
The chart and table above show Tonix Pharmaceuticals Holding Corp's shareholder equity by year and by quarter, including the growth rate.